Literature DB >> 10512717

Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.

J P Derrick1, M C Maiden, I M Feavers.   

Abstract

Many pathogens present highly variable surface proteins to their host as a means of evading immune responses. The structure of a peptide antigen corresponding to the subtype P1.7 variant of the porin PorA from the human pathogen Neisseria meningitidis was determined by solution of the X-ray crystal structure of the ternary complex of the peptide (ANGGASGQVK) in complex with a Fab fragment and a domain from streptococcal protein G to 1.95 A resolution. The peptide adopted a beta-hairpin structure with a type I beta-turn between residues Gly4P and Gly7P, the conformation of the peptide being further stabilised by a pair of hydrogen bonds from the side-chain of Asn2P to main-chain atoms in Val9P. The antigen binding site within the Fab formed a distinct crevice lined by a high proportion of apolar amino acids. Recognition was supplemented by hydrogen bonds from heavy chain residues Thr50H, Asp95H, Leu97H and Tyr100H to main-chain and side-chain atoms in the peptide. Complementarity-determining region (CDR) 3 of the heavy chain was responsible for approximately 50 % of the buried surface area formed by peptide-Fab binding, with the remainder made up from CDRs 1 and 3 of the light chain and CDRs 1 and 2 of the heavy chain. Knowledge of the structures of variable surface antigens such as PorA is an essential prerequisite to a molecular understanding of antigenic variation and its implications for vaccine design. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512717     DOI: 10.1006/jmbi.1999.3144

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Structure of the PilM-PilN inner membrane type IV pilus biogenesis complex from Thermus thermophilus.

Authors:  Vijaykumar Karuppiah; Jeremy P Derrick
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

2.  A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicity.

Authors:  T Scherf; R Kasher; M Balass; M Fridkin; S Fuchs; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

3.  Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.

Authors:  Elisabeth Wedege; Betsy Kuipers; Karin Bolstad; Harry van Dijken; L Oddvar Frøholm; Clementien Vermont; Dominique A Caugant; Germie van den Dobbelsteen
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

4.  A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.

Authors:  L Marsay; C Dold; C A Green; C S Rollier; G Norheim; M Sadarangani; M Shanyinde; C Brehony; A J Thompson; H Sanders; H Chan; K Haworth; J P Derrick; I M Feavers; M C Maiden; A J Pollard
Journal:  J Infect       Date:  2015-05-15       Impact factor: 6.072

5.  The biology of Neisseria adhesins.

Authors:  Miao-Chiu Hung; Myron Christodoulides
Journal:  Biology (Basel)       Date:  2013-07-29

6.  Molecular analysis of monoclonal antibodies to group variant capsular polysaccharide of Neisseria meningitidis: recurrent heavy chains and alternative light chain partners.

Authors:  Jody D Berry; Darren J Boese; Dennis K S Law; Wendell D Zollinger; Raymond S W Tsang
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

Review 7.  Superantigen Recognition and Interactions: Functions, Mechanisms and Applications.

Authors:  Anthony M Deacy; Samuel Ken-En Gan; Jeremy P Derrick
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

8.  Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp.

Authors:  Jacinto López-Sagaseta; Peter T Beernink; Federica Bianchi; Laura Santini; Elisabetta Frigimelica; Alexander H Lucas; Mariagrazia Pizza; Matthew J Bottomley
Journal:  Nat Commun       Date:  2018-02-06       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.